Rheumatoid arthritis (RA) is an inflammatory arthritis characterized by chronic joint inflammation, cartilage degradation, and bone erosion.

The Food and Drug Administration (FDA) has approved Avtozma ® (tocilizumab-anoh), a biosimilar to Actemra ® (tocilizumab), in both intravenous (IV) and subcutaneous (SC) formulations.

A team of Indian researchers have developed an innovative "self-actuating" drug delivery system that can change the treatment ...

Discover the reality behind Rheumatoid Arthritis, from its early onset potential to exercise benefits, backed by latest ...

The next big advance in treating diseases like rheumatoid arthritis could be tiny pulses of electricity delivered to the ...

While you wait for the groundhog to make his determination this weekend, take some time to buff up your knowledge of ...

Discover how high-content imaging identifies drug responses and disease activity in rheumatoid arthritis, paving the way for personalized treatments.

Announcing a new publication for Acta Materia Medica ... for alternative mRNA splicing and translational control in rheumatoid arthritis (RA). How RBP regulation differs between RA and ...